PubMed

Assessing the benefits of antiretroviral therapy.

Gulick RM.

Ann Intern Med. 2000 Sep 19;133(6):471-3. No abstract available. PMID: 10975966 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of response (CD4 cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy.

Barreiro PM, Dona MC, Castilla J, Soriano V.

AIDS. 1999 Mar 11;13(4):525-6. No abstract available. PMID: 10197384 [PubMed - indexed for MEDLINE]Related articles

Potency and durability of antiretroviral therapy.

Daar ES.

J Acquir Immune Defic Syndr. 2003 Oct 1;34 Suppl 2:S111-7. Review. No abstract available. PMID: 14703939 [PubMed - indexed for MEDLINE]Related articles

[Antiretroviral therapy in patients infected with HIV-1]

Corti ME.

Medicina (B Aires). 1998;58 Suppl 1:49-56. Spanish. No abstract available. PMID: 9674248 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral rounds. Reason to be worried.

Henry K, Hicks C.

AIDS Clin Care. 2000 Oct;12(10):82-3. No abstract available. PMID: 12211167 [PubMed - indexed for MEDLINE]Related articles

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study.

De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Zaccarelli M, Tozzi V, Ammassari A, Murri R, Antinori A.

AIDS. 2000 Jul 28;14(11):1655-6. No abstract available. PMID: 10983653 [PubMed - indexed for MEDLINE]Related articles

Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression.

d'Ettorre G, Mastroianni CM, Massetti AP, Lichtner M, D'Agostino C, Vullo V.

AIDS. 2005 May 20;19(8):841-2. No abstract available. PMID: 15867503 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patients.

Fätkenheuer G, Römer K, Kamps R, Salzberger B, Burger D.

AIDS. 2001 Nov 23;15(17):2334-5. No abstract available. PMID: 11698713 [PubMed - indexed for MEDLINE]Related articles

Using databases for clinical outcomes.

Clay PG.

AIDS. 2002 Jan 25;16(2):300-3. No abstract available. PMID: 11807321 [PubMed - indexed for MEDLINE]Related articles

CD4+ T-cell gain with nonnucleoside or protease inhibitors: convenience may not always be the most convenient.

Barreiro P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):758-60; author reply 760-1. No abstract available. PMID: 15167297 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral rounds. Too many options?

Walmsley S, Wilkin T, Moyle G.

AIDS Clin Care. 2009 Feb;21(2):13-5.PMID: 19253449 [PubMed - indexed for MEDLINE]Related articles

Protease inhibitors: opium of the masses?

Martinez LJ.

Res Initiat Treat Action. 2000 Sep;6(3):7-11. No abstract available. PMID: 11708167 [PubMed - indexed for MEDLINE]Related articles

Treatment of experienced patients and antiretroviral resistance issues from the 12th CROI.

Lucas GM.

Hopkins HIV Rep. 2005 Mar;17(2):1-3, 12. No abstract available. PMID: 16419315 [PubMed - indexed for MEDLINE]Related articles

New versions of antiretroviral guidelines contain some important changes.

Murphy MJ.

Fac Notes (New Orleans La). 1999 Jul-Aug;11(4):1-3. No abstract available. PMID: 11810843 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral rounds. Putting resistance to work.

Daar ES, Elion R.

AIDS Clin Care. 2004 Jul;16(7):56, 60. No abstract available. PMID: 15300926 [PubMed - indexed for MEDLINE]Related articles

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

García F, Alonso MM, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, Dalmau D, Ruiz I, Vidal F, Frances A, Segura F, Gomez-Sirvent JL, Cruceta A, Clotet B, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):26-35.PMID: 11064501 [PubMed - indexed for MEDLINE]Related articles

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration.

Lancet. 2004 Jul 3-9;364(9428):51-62.PMID: 15234856 [PubMed - indexed for MEDLINE]Related articles

Looking past two drugs, looking past three?

Mascolini M.

J Int Assoc Physicians AIDS Care. 1997 Feb;3(2):9-15, 18-22, 46.PMID: 11364100 [PubMed - indexed for MEDLINE]Related articles

Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.

Smith KY, Steffens CM, Truckenbrod A, Landay A, Al-Harthi L.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):544-5. No abstract available. PMID: 11981373 [PubMed - indexed for MEDLINE]Related articles

Switching meds: from protease inhibitors to non-nukes.

[No authors listed]

TreatmentUpdate. 2001 Winter;12(10):1-2. No abstract available. PMID: 11570061 [PubMed - indexed for MEDLINE]Related articles